0000950170-24-014006.txt : 20240212 0000950170-24-014006.hdr.sgml : 20240212 20240212180225 ACCESSION NUMBER: 0000950170-24-014006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldshleger Ilya CENTRAL INDEX KEY: 0001874147 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40690 FILM NUMBER: 24621742 MAIL ADDRESS: STREET 1: C/O RXSIGHT, INC. STREET 2: 100 COLUMBIA CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RxSight, Inc. CENTRAL INDEX KEY: 0001111485 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943268801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 949-521-7822 MAIL ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: CALHOUN VISION INC DATE OF NAME CHANGE: 20000410 4 1 ownership.xml 4 X0508 4 2024-02-09 0001111485 RxSight, Inc. RXST 0001874147 Goldshleger Ilya C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO CA 92656 false true false false Chief Operating Officer true Common Stock 2024-02-09 4 M false 5365 18.90 A 31840 D Common Stock 2024-02-09 4 M false 5000 23.04 A 36840 D Common Stock 2024-02-09 4 S false 5365 50.5012 D 31475 D Common Stock 2024-02-09 4 S false 5000 51 D 26475 D Common Stock 1372 I By spouse Stock Option (right to buy) 18.90 2024-02-09 4 M false 5365 0.00 D 2022-07-26 2028-07-25 Common Stock 5365 3995 D Stock Option (right to buy) 23.04 2024-02-09 4 M false 5000 0.00 D 2021-04-18 2029-04-17 Common Stock 5000 25000 D The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2023 by the Reporting Person. Represents the weighted average share price of an aggregate total of 5,365 shares sold in the price range of $50.50 to $50.54 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Shelley Thunen, as Attorney-in-Fact 2024-02-12